Welcome to our dedicated page for LHCG news (Ticker: LHCG), a resource for investors and traders seeking the latest updates and insights on LHCG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LHCG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LHCG's position in the market.
LHC Group, Inc. (NASDAQ: LHCG) reported a 2.0% increase in net service revenue for Q3 2022, totaling $576.9 million. The net income for common stockholders was $17.3 million, equating to $0.56 per diluted share, while adjusted net income reached $32.6 million, or $1.06 per adjusted diluted share. The adjusted EBITDA was $60.3 million. Due to the pending acquisition by UnitedHealth Group, no earnings call will follow this financial announcement.
LHC Group, Inc (NASDAQ: LHCG) will announce its third-quarter earnings results for the period ending September 30, 2022, on November 2, 2022. This announcement comes alongside their previously disclosed agreement to combine with Optum, leading to the decision not to hold a quarterly earnings call. LHC Group is a prominent provider of in-home healthcare services across 37 states and the District of Columbia, employing 29,000 staff to deliver care to 68% of the U.S. population aged 65 and older.
LHC Group (NASDAQ: LHCG) and the University of Maryland Medical System (UMMS) have announced a joint venture to improve in-home healthcare services across Maryland. This partnership will cover 20 counties and Baltimore, with LHC Group anticipating an annual revenue increase of about $4.8 million. The agreement is expected to be finalized in Q4 2022. LHC Group will take majority ownership and management control, enhancing patient access to essential healthcare services in their homes.
LHC Group (NASDAQ: LHCG) has announced its acquisition of Three Rivers Home Health, based in Eastman, Georgia, expanding its services across 36 counties. The deal, expected to close in Q4 2022, brings an anticipated annual revenue of approximately $12 million without significantly affecting 2022 diluted earnings per share. This acquisition aligns with LHC Group's strategy of expanding its service area and co-locating multiple healthcare services. Three Rivers will continue its operations under its current name, ensuring uninterrupted care for its patients.
LHC Group, Inc. (NASDAQ: LHCG) reported a 5.5% increase in net service revenue, reaching $576.2 million for Q2 2022. Net income attributed to common stockholders was $10.6 million, or $0.35 per diluted share, while adjusted net income stood at $29.8 million, translating to $0.98 per diluted share. The company’s adjusted EBITDA was $53.0 million. Noteworthy operational highlights include improving quality and patient satisfaction scores, with home health ratings rising from 4.20 to 4.25. Hospice admissions also grew by 5.5%. Due to its pending acquisition by UnitedHealth Group, no earnings call will be held.
LHC Group, Inc. is set to release its second quarter earnings results on August 3, 2022, after market close. The announcement follows the company's previously disclosed agreement to combine with Optum. Notably, LHC Group will not hold a quarterly earnings call this time to discuss the earnings results. The company serves as a key provider of in-home healthcare services across 37 states and the District of Columbia, reaching 68% of the U.S. population aged 65 and older. LHC employs around 29,000 individuals in various healthcare roles.
LHC Group, Inc. (NASDAQ: LHCG) reported a strong financial performance for Q1 2022, with a net service revenue increase of 8.9%, reaching $571.5 million. Adjusted net income rose to $33.4 million, translating to $1.09 per diluted share. The company also improved its Home Health quality star ratings from 4.12 to 4.25, reflecting its commitment to patient satisfaction. Organic growth in home health and hospice admissions increased by 1.6% and 4%, respectively. Notably, LHC Group announced a joint venture with Archbold Medical Center, enhancing its in-home service offerings.
LHC Group (NASDAQ: LHCG) has finalized a joint venture with Archbold Medical Center to provide in-home healthcare services in seven Georgia counties. This partnership expands LHC Group's service area, allowing coverage in Thomas, Brooks, Grady, Colquitt, Mitchell, Decatur, and Seminole counties. The company now operates over 556 locations nationwide and is a key provider for over 400 hospitals in the U.S., enhancing its position in the home health care market.
LHC Group, Inc. (NASDAQ: LHCG) will release its first-quarter 2022 earnings results on May 4, 2022, after market close. Due to its upcoming merger with Optum, the company will not hold a quarterly earnings call.
AM Best has confirmed that the Credit Ratings of UnitedHealth Group (NYSE: UNH) and its insurance subsidiaries remain stable following the announcement of its acquisition of LHC Group Inc. (NASDAQ: LHCG) for approximately
FAQ